Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

US Stock Market Move | SoftBank-backed PayPay (PAYP.US) debuted on the U.S. stock market with an opening increase of over 13%.

Federal Reserve Vice Chairman Bowman: New banking capital rules will be announced next week aimed at encouraging increased lending.

US Stock Market Move | China's new forceful car company defies market trends and rises. XPeng, Inc. ADR Sponsored Class A(XPEV.US) surged more than 4%.
US Stock Market Move | SoftBank-backed PayPay (PAYP.US) debuted on the U.S. stock market with an opening increase of over 13%.

Federal Reserve Vice Chairman Bowman: New banking capital rules will be announced next week aimed at encouraging increased lending.

US Stock Market Move | China's new forceful car company defies market trends and rises. XPeng, Inc. ADR Sponsored Class A(XPEV.US) surged more than 4%.

RECOMMEND

“A+H” Team Continues To Expand Hard Technology Firms Accelerate Global Deployment
11/03/2026

Anti‑Stagflation Theme Guides Hong Kong Allocation Institutions Identify Power And Energy Assets As Short‑Term Core
11/03/2026

U.S. Equities Enter “Always‑On” Trading Era Nasdaq Advances Stock Tokenization Framework
11/03/2026


